Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Granel

Showing results (541-550 of 546) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 546 results.
Arthritis & Rheumatology (Hoboken, N.J.)|August 21, 2024
Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter StudyAndrea Di Matteo, Stefano Di Donato, Gianluca Smerilli, et al.
Annales De Dermatologie Et De Venereologie|February 7, 2024
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concernsM Amini-Adle, J-P Arnault, F Aubin, et al.
Seminars in Arthritis and Rheumatism|September 6, 2025
Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre studyStefano Di Donato, Gianluca Smerilli, Andrea Becciolini, et al.
Annals of the Rheumatic Diseases|March 5, 2024
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre studyAndrea Di Matteo, Gianluca Smerilli, Stefano Di Donato, et al.
Clinical Rheumatology|April 25, 2019
Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASARRoberto Ranza, Maria Celina de la Vega, Ieda Maria Magalhães Laurindo, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 55

Showing results (541-550 of 546) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 546 results.
Arthritis & Rheumatology (Hoboken, N.J.)|August 21, 2024
Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter StudyAndrea Di Matteo, Stefano Di Donato, Gianluca Smerilli, et al.
Annales De Dermatologie Et De Venereologie|February 7, 2024
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concernsM Amini-Adle, J-P Arnault, F Aubin, et al.
Seminars in Arthritis and Rheumatism|September 6, 2025
Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre studyStefano Di Donato, Gianluca Smerilli, Andrea Becciolini, et al.
Annals of the Rheumatic Diseases|March 5, 2024
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre studyAndrea Di Matteo, Gianluca Smerilli, Stefano Di Donato, et al.
Clinical Rheumatology|April 25, 2019
Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASARRoberto Ranza, Maria Celina de la Vega, Ieda Maria Magalhães Laurindo, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 55